# GraniteShares YieldBOOST Biotech ETF (BIOY) — Overview

BIOY · NASDAQ · Fund

Canonical page: https://www.lighthorse.io/tickers/bioy

## Price

Last close $19.62 on Oct 15, 2026. 52-week range $19.36 – $25.27.

## Fund profile

BIOY's primary investment objective is to achieve 3 times (300%) the income generated from selling options on S&P Biotechnology Select Industry Index.

| Metric | Value |
| --- | --- |
| Issuer | GraniteShares Advisors LLC |
| Industry | Healthcare |
| Inception | May 5, 2026 |
| Assets under management | $1.4M |
| Expense ratio | 1.07% |
| Net asset value | $19.59 (as of Oct 15, 2026) |
| Distributions | Weekly |
| Leverage | 3x |

## Frequently Asked Questions

### What is GraniteShares YieldBOOST Biotech ETF (BIOY)?

BIOY's primary investment objective is to achieve 3 times (300%) the income generated from selling options on S&P Biotechnology Select Industry Index.

### What is BIOY's expense ratio?

GraniteShares YieldBOOST Biotech ETF charges an annual expense ratio of 1.07%. The fund is issued by GraniteShares Advisors LLC.

### How large is BIOY?

GraniteShares YieldBOOST Biotech ETF manages $1.4M in assets and has traded since May 5, 2026.

### How do I buy shares of GraniteShares YieldBOOST Biotech ETF (BIOY)?

BIOY trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).